Shelby Giza is the Director of Business Development for Applications at Space Tango, where she aligns corporate objectives with groundbreaking opportunities in health and technology for space-based research and manufacturing. Shelby bridges strategic vision with tactical implementation, fostering seamless collaboration among internal teams and external partners. Her leadership in advancing best practices for the ideation and development of patient therapeutics in space is instrumental in shaping a thriving low-Earth-orbit economy. Working closely with research institutions, industry pioneers, and government stakeholders, Shelby drives partnerships that unlock new opportunities and expand the market for space-based science and manufacturing solutions.
With over 20 years of translational medicine research experience, Shelby delivers evidence-based insights to ensure the design and development of advanced hardware and facilities tailored to the diverse needs of scientific ventures. She has played a pivotal role in the research and development of groundbreaking therapeutics and technologies. She brings International Space Station (ISS) user experience, having supported the development of a 3D human muscle tissue chip in collaboration with Space Tango and the Malany Lab at the University of Florida, which flew aboard SpaceX CRS-21. Shelby received her Bachelor of Science degree in Chemistry from the University of Massachusetts Dartmouth and is currently pursuing an MBA at Syracuse University.